{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T11:40:05Z","timestamp":1750160405993,"version":"3.41.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zevra Therapeutics"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ymgmr.2025.101233","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T16:21:20Z","timestamp":1748449280000},"page":"101233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy results from a 12-month double-blind randomized trial of arimoclomol for treatment of Niemann-Pick disease type C (NPC): Presenting a rescored 4-domain NPC Clinical Severity Scale"],"prefix":"10.1016","volume":"43","author":[{"given":"Eugen","family":"Mengel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc C.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalia M.","family":"Da Riol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Del Toro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Deodato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Gautschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Grunewald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine Weller","family":"Gr\u00f8nborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Harmatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia B.","family":"Hennermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9n\u00e9dicte","family":"H\u00e9ron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther M.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agathe","family":"Roubertie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saikat","family":"Santra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Tylki-Szymanska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"LaGorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Berry-Kravis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Forbes D.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Himmelstrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis","family":"Mickle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Guenther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine \u00ed","family":"Dali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2025.101233_bb0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1600-0854.2010.01032.x","article-title":"Lipids on trial: the search for the offending metabolite in Niemann-pick type C disease","volume":"11","author":"Lloyd-Evans","year":"2010","journal-title":"Traffic"},{"key":"10.1016\/j.ymgmr.2025.101233_bb0010","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1194\/jlr.R048090","article-title":"Lysosomal storage diseases and the heat shock response: convergences and therapeutic opportunities","volume":"55","author":"Ingemann","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-genom-091212-153412","article-title":"Disorders of cholesterol metabolism and their unanticipated convergent mechanisms of disease","volume":"15","author":"Platt","year":"2014","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-018-0785-7","article-title":"Consensus clinical management guidelines for Niemann-pick disease type C","volume":"13","author":"Geberhiwot","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-pick disease type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0030","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ymgme.2019.02.004","article-title":"Evaluation of age of death in Niemann-pick disease, type C: utility of disease support group websites to understand natural history","volume":"126","author":"Bianconi","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0035","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ymgme.2012.03.012","article-title":"Recommendations for the diagnosis and management of Niemann-pick disease type C: an update","volume":"106","author":"Patterson","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajmg.b.30969","article-title":"Linear clinical progression, independent of age of onset, in Niemann-pick disease, type C","volume":"153B","author":"Yanjanin","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-015-0511-1","article-title":"Observational cohort study of the natural history of Niemann-pick disease type C in the UK: a 5-year update from the UK clinical database","volume":"15","author":"Imrie","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1212\/WNL.0b013e3181e6210e","article-title":"White and gray matter alterations in adults with Niemann-pick disease type C: a cross-sectional study","volume":"75","author":"Walterfang","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.ymgmr.2025.101233_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-8-35","article-title":"Niemann-pick disease type C clinical database: cognitive and coordination deficits are early disease indicators","volume":"8","author":"Stampfer","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13023-018-0880-9","article-title":"Annual severity increment score as a tool for stratifying patients with Niemann-pick disease type C and for recruitment to clinical trials","volume":"13","author":"Cortina-Borja","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0065","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mus.21059","article-title":"Arimoclomol at dosages up to 300 mg\/day is well tolerated and safe in amyotrophic lateral sclerosis","volume":"38","author":"Cudkowicz","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgmr.2025.101233_bb0070","first-page":"PO","article-title":"Arimoclomol safety profile in the treatment of NPC in a real-world setting: long-term data from and expanded access program in the USA","author":"Ficicioglu","year":"2024","journal-title":"Soc. Study Inborn Errors Metabol. Ann. Sympos."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0075","first-page":"PO","article-title":"Arimoclomol for the treatment of NPC in a real-world setting: long-term outcomes from an expanded access program in the USA","author":"Al-Hertani","year":"2024","journal-title":"Soc. Study Inborn Errors Metabol. Ann. Sympos."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0080","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann-pick C disease: a randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0085","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0883073809344222","article-title":"Long-term miglustat therapy in children with Niemann-pick disease type C","volume":"25","author":"Patterson","year":"2010","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ymgme.2009.12.006","article-title":"Miglustat in adult and juvenile patients with Niemann-pick disease type C: long-term data from a clinical trial","volume":"99","author":"Wraith","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0095","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/jimd.12245","article-title":"Long-term survival outcomes of patients with Niemann-pick disease type C receiving miglustat treatment: a large retrospective observational study","volume":"43","author":"Patterson","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-020-01363-2","article-title":"Treatment outcomes following continuous miglustat therapy in patients with Niemann-pick disease type C: a final report of the NPC registry","volume":"15","author":"Patterson","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0105","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1001\/jamaneurol.2020.3241","article-title":"Association of Miglustat with Swallowing Outcomes in Niemann-pick disease, type C1","volume":"77","author":"Solomon","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0110","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/jimd.12428","article-title":"Efficacy and safety of arimoclomol in Niemann-pick disease type C: results from a double-blind, randomised, placebo-controlled, multinational phase 2\/3 trial of a novel treatment","volume":"44","author":"Mengel","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13023-021-01719-2","article-title":"Validation of the 5-domain Niemann-pick type C clinical severity scale","volume":"16","author":"Patterson","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0120","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s13023-021-02115-6","article-title":"International consensus on clinical severity scale use in evaluating Niemann\u2013Pick disease Type C in paediatric and adult patients: results from a Delphi Study","volume":"16","author":"Evans","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2025.101233_bb0125","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.ymgmr.2025.101233_bb0130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13023-024-03241-7","article-title":"Swallowing characterization of adult-onset Niemann-pick, type C1 patients","volume":"19","author":"Solomon","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"year":"2006","series-title":"Measuring Health: A Guide to Rating Scales and Questionnaires","author":"McDowell","key":"10.1016\/j.ymgmr.2025.101233_bb0135"},{"key":"10.1016\/j.ymgmr.2025.101233_bb0140","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s13023-022-02472-w","article-title":"Phenotypic expression of swallowing function in Niemann-pick disease type C1","volume":"17","author":"Solomon","year":"2022","journal-title":"Orphanet J. Rare Dis."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426925000485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426925000485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T11:25:28Z","timestamp":1750159528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426925000485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":28,"alternative-id":["S2214426925000485"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2025.101233","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy results from a 12-month double-blind randomized trial of arimoclomol for treatment of Niemann-Pick disease type C (NPC): Presenting a rescored 4-domain NPC Clinical Severity Scale","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2025.101233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101233"}}